[HTML][HTML] Mass Cytometry Identifies Expansion of T-bet+ B Cells and CD206+ Monocytes in Early Multiple Sclerosis

L Couloume, J Ferrant, S Le Gallou, M Mandon… - Frontiers in …, 2021 - frontiersin.org
Multiple sclerosis (MS) is an immune-driven demyelinating disease of the central nervous
system. Immune cell features are particularly promising as predictive biomarkers due to their …

Mass Cytometry Identifies Expansion of T-bet+ B Cells and CD206+ Monocytes in Early Multiple Sclerosis

L Couloume, J Ferrant, S Le Gallou… - … in Immunology (Web), 2021 - jglobal.jst.go.jp
Mass Cytometry Identifies Expansion of T-bet<sup>+</sup> B Cells and CD206<sup>+</sup>
Monocytes in Early Multiple Sclerosis | Article Information | J-GLOBAL Art J-GLOBAL ID:202102278724026637 …

Mass Cytometry Identifies Expansion of T-bet (+) B Cells and CD206 (+) Monocytes in Early Multiple Sclerosis

L Couloume, J Ferrant, S Le Gallou… - Frontiers in …, 2021 - inria.hal.science
Multiple sclerosis (MS) is an immune-driven demyelinating disease of the central nervous
system. Immune cell features are particularly promising as predictive biomarkers due to their …

Mass Cytometry Identifies Expansion of T-bet+ B Cells and CD206+ Monocytes in Early Multiple Sclerosis

L Couloume, J Ferrant, S Le Gallou… - Frontiers in …, 2021 - pubmed.ncbi.nlm.nih.gov
Multiple sclerosis (MS) is an immune-driven demyelinating disease of the central nervous
system. Immune cell features are particularly promising as predictive biomarkers due to their …

[HTML][HTML] Mass Cytometry Identifies Expansion of T-bet+ B Cells and CD206+ Monocytes in Early Multiple Sclerosis

L Couloume, J Ferrant, S Le Gallou… - Frontiers in …, 2021 - ncbi.nlm.nih.gov
Multiple sclerosis (MS) is an immune-driven demyelinating disease of the central nervous
system. Immune cell features are particularly promising as predictive biomarkers due to their …

Mass Cytometry Identifies Expansion of T-bet+ B Cells and CD206+ Monocytes in Early Multiple Sclerosis.

L Couloume, J Ferrant, S Le Gallou… - Frontiers in …, 2021 - europepmc.org
Multiple sclerosis (MS) is an immune-driven demyelinating disease of the central nervous
system. Immune cell features are particularly promising as predictive biomarkers due to their …

Mass Cytometry Identifies Expansion of T-bet (+) B Cells and CD206 (+) Monocytes in Early Multiple Sclerosis

L Couloume, J Ferrant, S Le Gallou, M Mandon… - Frontiers in …, 2021 - hal.science
Multiple sclerosis (MS) is an immune-driven demyelinating disease of the central nervous
system. Immune cell features are particularly promising as predictive biomarkers due to their …

Mass Cytometry Identifies Expansion of T-bet+ B Cells and CD206+ Monocytes in Early Multiple Sclerosis.

L Couloume, J Ferrant, S Le Gallou… - Frontiers in …, 2021 - europepmc.org
Multiple sclerosis (MS) is an immune-driven demyelinating disease of the central nervous
system. Immune cell features are particularly promising as predictive biomarkers due to their …

[PDF][PDF] Mass Cytometry Identifies Expansion of T-bet+ B Cells and CD206+ Monocytes in Early Multiple Sclerosis. Front. Immunol. 12: 653577. doi: 10.3389/fimmu

L Couloume, J Ferrant, S Le Gallou, M Mandon, R Jean… - 2021 - hal.science
Multiple sclerosis (MS) is an immune-driven demyelinating disease of the central nervous
system. Immune cell features are particularly promising as predictive biomarkers due to their …